Free Trial

Gradient Investments LLC Has $34.38 Million Stake in Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

  • Gradient Investments LLC reduced its stake in Procter & Gamble by 14.8%, owning 215,788 shares valued at approximately $34.38 million as of its latest SEC filing.
  • Procter & Gamble reported revenue of $20.89 billion for the quarter, outperforming analysts' expectations, and declared a quarterly dividend of $1.0568 per share.
  • Institutional investors hold over 65.77% of Procter & Gamble's stock, with several firms making significant adjustments to their ownership during the first quarter of the year.
  • Five stocks we like better than Procter & Gamble.

Gradient Investments LLC trimmed its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 14.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 215,788 shares of the company's stock after selling 37,538 shares during the quarter. Gradient Investments LLC's holdings in Procter & Gamble were worth $34,379,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in the company. Northern Trust Corp lifted its holdings in shares of Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock valued at $5,051,930,000 after buying an additional 248,792 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Procter & Gamble by 3.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock valued at $2,966,252,000 after buying an additional 583,629 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Procter & Gamble by 6.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company's stock valued at $2,947,146,000 after buying an additional 1,018,865 shares during the last quarter. Finally, Royal Bank of Canada lifted its holdings in shares of Procter & Gamble by 0.6% during the 1st quarter. Royal Bank of Canada now owns 17,273,679 shares of the company's stock valued at $2,943,779,000 after buying an additional 111,162 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Evercore ISI restated an "in-line" rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Barclays set a $164.00 target price on Procter & Gamble and gave the stock an "equal weight" rating in a report on Thursday, July 31st. Wells Fargo & Company reduced their target price on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Finally, UBS Group set a $180.00 target price on Procter & Gamble and gave the stock a "buy" rating in a report on Wednesday, July 30th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $175.12.

Get Our Latest Stock Report on Procter & Gamble

Procter & Gamble Stock Performance

Shares of NYSE PG opened at $158.02 on Monday. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The business's 50 day moving average is $156.21 and its two-hundred day moving average is $161.77. The company has a market cap of $369.85 billion, a P/E ratio of 24.27, a P/E/G ratio of 4.17 and a beta of 0.36. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company's revenue for the quarter was up 1.7% on a year-over-year basis. During the same period in the previous year, the business posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were given a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble's payout ratio is currently 64.82%.

Insider Buying and Selling

In other Procter & Gamble news, COO Shailesh Jejurikar sold 13,039 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $2,050,643.53. Following the transaction, the chief operating officer directly owned 28,036 shares of the company's stock, valued at $4,409,221.72. The trade was a 31.74% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,548,952.23. Following the sale, the insider owned 182,422 shares in the company, valued at approximately $28,689,507.94. This represents a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is currently owned by company insiders.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Brace for Fed: What Investors Need to Know Before Wednesday
3 Biotech Stocks Under $5 With Huge Upside
Revealed: Congress’ Biggest Stock Moves This Month

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines